April 16, 2020

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Category: Article Summary

Topic: Testing and Treatment

• This study demonstrates that renin-angiotensin system (RAS) inhibitors improve the clinical outcomes of COVID-19 patients with hypertension, suggesting that these patients could benefit from the persistent or preferential usage of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs) for antihypertensive treatment.

Meng et al. (Mar 31, 2020). Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Micro & Infect. https://doi.org/10.1080/22221751.2020.1746200